不可逆电穿孔用于前列腺癌，作为先前放疗和冷冻治疗后的挽救性治疗。
Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and Cryotherapy.
作者信息
Murray Katie S, Akin Oguz, Coleman Jonathan A
机构信息
Division of Urology, Department of Surgery, University of Missouri Columbia, MO.
Body Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center New York, NY.
出版信息
Rev Urol. 2017;19(4):268-272. doi: 10.3909/riu0755.
Abstract
Salvage treatment options after localized primary treatment failure of prostate cancer are limited and associated with risk for serious complications. We report on the management details of a 57-year-old African American man treated with partial-gland ablation using irreversible electroporation following local recurrence after brachytherapy and prior salvage cryoablation. Therapeutic and functional outcomes were assessed by conventional means, including serum prostate-specific antigen values and prostate biopsy results.
摘要
前列腺癌局部初次治疗失败后的挽救治疗选择有限，且伴有严重并发症风险。我们报告了一名57岁非裔美国男性的治疗细节，该患者在近距离放射治疗后局部复发，且之前接受过挽救性冷冻消融，之后采用不可逆电穿孔进行部分腺体消融治疗。通过常规方法评估治疗和功能结果，包括血清前列腺特异性抗原值和前列腺活检结果。
相似文献
1
Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and Cryotherapy.
Rev Urol. 2017;19(4):268-272. doi: 10.3909/riu0755.
2
Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze.
Clin Genitourin Cancer. 2019 Aug;17(4):e831-e836. doi: 10.1016/j.clgc.2019.05.014. Epub 2019 May 28.
3
Salvage Cryoablation for Recurrent Prostate Cancer Following Radiation-A Comprehensive Review.
Cancers (Basel). 2024 Jul 31;16(15):2717. doi: 10.3390/cancers16152717.
4
Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
BJU Int. 2017 Nov;120 Suppl 3:51-58. doi: 10.1111/bju.13991. Epub 2017 Sep 19.
5
[Salvage cryotherapy for recurrent prostate cancer after radiotherapy failure: principles, indications, patient selection, oncological results and morbidity].
Cancer Radiother. 2014 Nov;18(7):701-8. doi: 10.1016/j.canrad.2014.04.002. Epub 2014 Jun 6.
6
Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.
Prostate. 2015 Jan;75(1):1-7. doi: 10.1002/pros.22881. Epub 2014 Oct 4.
7
Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.
J Urol. 2016 Sep;196(3):883-90. doi: 10.1016/j.juro.2016.02.2986. Epub 2016 Apr 23.
8
Diagnosis and management of local recurrence after low-dose-rate brachytherapy.
Brachytherapy. 2015 Mar-Apr;14(2):124-30. doi: 10.1016/j.brachy.2014.08.046. Epub 2014 Sep 16.
9
Prostate specific antigen only progression of prostate cancer.
J Urol. 2000 Jun;163(6):1632-42.
10
Salvage Local Treatments After Focal Therapy for Prostate Cancer.
Eur Urol Oncol. 2019 Sep;2(5):526-538. doi: 10.1016/j.euo.2019.03.008. Epub 2019 Apr 15.
引用本文的文献
1
Focal therapy for primary and salvage prostate cancer treatment: a narrative review.
Transl Androl Urol. 2021 Jul;10(7):3144-3154. doi: 10.21037/tau-20-1212.
2
Complications, oncological and functional outcomes of salvage treatment options following focal therapy for localized prostate cancer: a systematic review and a comprehensive narrative review.
World J Urol. 2019 Aug;37(8):1517-1534. doi: 10.1007/s00345-019-02642-9. Epub 2019 Feb 1.
本文引用的文献
1
Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.
J Urol. 2016 Sep;196(3):883-90. doi: 10.1016/j.juro.2016.02.2986. Epub 2016 Apr 23.
2
Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study.
J Urol. 2016 Aug;196(2):552-9. doi: 10.1016/j.juro.2016.02.2977. Epub 2016 Mar 19.
3
Feasibility of catheter-directed intraluminal irreversible electroporation of porcine ureter and acute outcomes in response to increasing energy delivery.
J Vasc Interv Radiol. 2015 Jul;26(7):1059-66. doi: 10.1016/j.jvir.2015.01.020. Epub 2015 Mar 11.
4
Safety and feasibility of Irreversible Electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective study.
Dig Surg. 2015;32(2):90-7. doi: 10.1159/000375323. Epub 2015 Feb 28.
5
Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer.
Prostate Cancer Prostatic Dis. 2014 Dec;17(4):343-7. doi: 10.1038/pcan.2014.33. Epub 2014 Sep 2.
6
Cryotherapy for primary treatment of prostate cancer: intermediate term results of a prospective study from a single institution.
Prostate Cancer. 2014;2014:571576. doi: 10.1155/2014/571576. Epub 2014 Feb 20.
7
In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
Prostate. 2014 May;74(5):458-68. doi: 10.1002/pros.22760. Epub 2014 Jan 17.
8
SIU/ICUD Consultation on Urethral Strictures: Posterior urethral stenosis after treatment of prostate cancer.
Urology. 2014 Mar;83(3 Suppl):S59-70. doi: 10.1016/j.urology.2013.08.036. Epub 2013 Dec 20.
9
TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.
BJU Int. 2013 Oct;112(6):766-74. doi: 10.1111/bju.12265.
10
Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model.
Cardiovasc Intervent Radiol. 2013 Apr;36(2):512-20. doi: 10.1007/s00270-012-0452-7. Epub 2012 Aug 15.
Zotero 插件